119 related articles for article (PubMed ID: 2584711)
1. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.
Taylor RP; Wright EL; Pocanic F
J Immunol; 1989 Dec; 143(11):3626-31. PubMed ID: 2584711
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes.
Edberg JC; Tosic L; Wright EL; Sutherland WM; Taylor RP
J Immunol; 1988 Dec; 141(12):4258-65. PubMed ID: 3198918
[TBL] [Abstract][Full Text] [Related]
3. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
Edberg JC; Wright E; Taylor RP
J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the endocytosis of immune complexes.
van Es LA; Daha MR
Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
Horgan C; Burge J; Crawford L; Taylor RP
J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
[TBL] [Abstract][Full Text] [Related]
8. Binding and catabolism of aggregated immunoglobulins containing C3b by U937 cells.
Mehta RL; Takahashi H; Rudick RA; Knutson DW
J Immunol; 1986 Mar; 136(5):1765-71. PubMed ID: 2936811
[TBL] [Abstract][Full Text] [Related]
9. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
Emlen W; Burdick G; Carl V; Lachmann PJ
J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
[TBL] [Abstract][Full Text] [Related]
10. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
Taylor RP; Pocanic F; Reist C; Wright EL
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
[TBL] [Abstract][Full Text] [Related]
11. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
12. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
13. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys.
Reist CJ; Liang HY; Denny D; Martin EN; Scheld WM; Taylor RP
Eur J Immunol; 1994 Sep; 24(9):2018-25. PubMed ID: 8088321
[TBL] [Abstract][Full Text] [Related]
14. Clearance kinetics and immunochemistry in rabbits of soluble antibody/DNA immune complexes. Effects of antibody class and DNA conformation.
Edberg JC; Kujala GA; Taylor RP
J Immunol; 1987 Jul; 139(1):180-7. PubMed ID: 3584985
[TBL] [Abstract][Full Text] [Related]
15. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
Kávai M; Rasmussen JM; Baatrup G; Zsindely A; Svehag SE
Scand J Immunol; 1988 Jul; 28(1):123-8. PubMed ID: 2969612
[TBL] [Abstract][Full Text] [Related]
16. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
17. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
Taylor RP; Burge J; Horgan C; Shasby DM
J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
Edberg JC; Kimberly RP; Taylor RP
Eur J Immunol; 1992 Jun; 22(6):1333-9. PubMed ID: 1376254
[TBL] [Abstract][Full Text] [Related]
19. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
[TBL] [Abstract][Full Text] [Related]
20. The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies.
Taylor RP; Kujala G; Edberg JC; Foreman P; Davis JS; Wright E
J Immunol; 1986 May; 136(10):3785-92. PubMed ID: 3701061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
